NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
November 7, 2022
With the fight against antibiotic resistance increasing, so is the importance of a more sensitive and faster diagnosis to offer a personalised treatment. CerTest has responded to that by developing a range of multiplex reactions for the detection and differentiation of multiple genes, which confer resistance to antibiotics – chiefly, through its Viasure products.
Download to find out more.